Trademark: 79347429
Word
EPIMOGRIFY
Status Date
Tuesday, February 6, 2024
Registration Number
7295995
Registration Date
Tuesday, February 6, 2024
Filing Date
Tuesday, March 22, 2022
Published for Opposition
Tuesday, November 21, 2023
40 Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs; custom manufacture of transcription factors, ligands, cell surface receptors, cells, cell therapies and gene therapies; information, advisory and consultancy services in relation to all of the aforesaid services
9 Downloadable bioinformatics software for epigenomic data analysis; downloadable computer software platforms for epigenomic data analysis in the field of cell and gene therapies; downloadable bioinformatics computer software platforms for epigenomic data analysis in the field of cell and gene therapies; scientific apparatus for measuring and analysing scientific study data, namely, apparatus for recording, transmission or reproduction of data, video, audio, images and text; data analysis apparatus,namely, data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software
5 Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical, biopharmaceutical and veterinary preparations for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; pharmaceutical and biopharmaceutical preparations for cell and gene therapy; biological preparations for modifying human or animal cells for medical or therapeutic purposes, namely, transcription factors, ligands and cell surface receptors for use in maintaining cell identity and to support the reprogramming of cells in chemically defined media; biological, chemical and biochemical reagents for medical use; cells for medical or clinical use; vaccines
1 Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for scientific and research use; chemical substances, namely transcription factors and ligands for scientific and industrial use; cells for scientific and research use
44 Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; cell and gene therapy services, namely, manipulation of human and animal cells for therapeutic purposes; medical services, namely, reinsertion of cells into human and animal patients for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies
42 Scientific and technological services namely research and design analysis in the field of cell and gene therapies; industrial research services in the field of cell and gene therapies; medical and veterinary research services namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy and gene therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; medical laboratory services; medical research laboratory services, in the field of cell and gene therapies; software as a service (SaaS) services featuring software for use in epigenomic data analysis; platform as a service (Paas) services featuring a bioinformatics software platform for use in manufacturing therapeutics; providing an online non-downloadable bioinformatics software platform for identifying transcription factors, ligands and cell surface receptors to turn one cell type into another cell type; providing an online non-downloadable bioinformatics platform for identifying transcription factors, ligands and cell surface receptors to maintain cell conversion; advisory and consultancy relating to all the aforesaid services
Aug 18, 2022
Sn Assigned For Sect 66a Appl From Ib
Aug 19, 2022
New Application Office Supplied Data Entered
Aug 23, 2022
Application Filing Receipt Mailed
Jan 4, 2023
Assigned To Examiner
Jan 17, 2023
Non-Final Action Written
Jan 18, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Mar 10, 2023
Refusal Processed By Mpu
Mar 10, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Apr 6, 2023
Refusal Processed By Ib
Sep 7, 2023
Teas Response To Office Action Received
Sep 7, 2023
Correspondence Received In Law Office
Sep 7, 2023
Teas/Email Correspondence Entered
Oct 16, 2023
Final Refusal Written
Oct 16, 2023
Final Refusal E-Mailed
Oct 16, 2023
Notification Of Final Refusal Emailed
Oct 18, 2023
Examiners Amendment -Written
Oct 18, 2023
Examiners Amendment E-Mailed
Oct 18, 2023
Notification Of Examiners Amendment E-Mailed
Oct 18, 2023
Examiner's Amendment Entered
Oct 18, 2023
Approved For Pub - Principal Register
Nov 1, 2023
Notification Of Possible Opposition Sent To Ib
Nov 1, 2023
Notification Of Notice Of Publication E-Mailed
Nov 1, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 21, 2023
Notification Processed By Ib
Nov 21, 2023
Published For Opposition
Nov 21, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2024
Notification Of Possible Opposition Sent To Ib
Jan 24, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 6, 2024
Registered-Principal Register
Feb 6, 2024
Notice Of Registration Confirmation Emailed
Feb 13, 2024
Notification Of Possible Opposition - Processed By Ib
May 6, 2024
Final Disposition Notice Created, To Be Sent To Ib
May 9, 2024
Final Disposition Notice Sent To Ib
May 9, 2024
Final Disposition Processed
Trademark Alertz updated from USPTO on 2030-01-24
